Clinical features and survival outcomes in patients with multiple myeloma: Analysis of web-based data from the korean myeloma registry

Acta Haematologica

Volumn 122, Issue 4, 2009, Pages 200-210

  Kim, Seok Jin ^a   Kim, Kihyun ^a   Kim, Byung Soo ^b   Jo, Deog Yeon ^c   Kang, Hye Jin ^d   Kim, Jin Seok ^e   Mun, Yeung Chul ^f   Kim, Chul Soo ^g   Sohn, Sang Kyun ^h   Eom, Hyeon Seok ⁱ   Kwak, Jae Yong ^j   Shim, Hyeok ^k   Yoon, Hwi Joong ^l   Jin, Jong Youl ^m   Min, Chang Ki ⁿ   Shin, Hyunchoon ^o   Won, Jong Ho ^p   Lee, Je Jung ^q   Kwon, Jung Hye ^r   Joo, Young Don ^s   Do, Young Rok ^t   Kim, Sung Hyun ^u   Oh, Sukjoong ^v   Suh, Cheolwon ^w   Lee, Junglim ^x   Yoon, Sung Soo ^y   Kim, Min Kyoung ^z   Bang, Soo Mee ^aa   Ryoo, Hun Mo ^ab   Kim, Bong Seog ^ac   Kim, Hawk ^ad   Kim, Hyo Jung ^r   Kim, Yang Soo ^ae   Park, Chong Won ⁿ   Lee, Gyeong Won ^af   Shin, Ho Jin ^ag   Park, Seong Kyu ^ah   Park, Joon Seong ^ai   Kim, Ho Young ^r,aj   Lee, Dong Soon ^y   Lee, Jae Hoon ^ak   more..

^a Sungkyunkwan University   (South Korea)

^b Korea University Ansan Hospital   (South Korea)

^c Chungnam National University College of Medicine   (South Korea)

^d Korea Cancer Center Hospital   (South Korea)

^e Yonsei University College of Medicine   (South Korea)

^f Ewha Womans University School of Medicine   (South Korea)

^g Inha University Hospital   (South Korea)

^h Kyungpook National University Hospital   (South Korea)

ⁱ National Cancer Center   (South Korea)

^j Chonbuk National University   (South Korea)

^k Wonkwang University   (South Korea)

^l Kyung Hee University Hospital   (South Korea)

^m The Catholic University of Korea   (South Korea)

ⁿ The Catholic University of Korea   (South Korea)

^o Chooncheon Sacred Heart Hospital

^p Soonchunhyang University College of Medicine   (South Korea)

^q Chonnam National University   (South Korea)

^r Hallym University   (South Korea)

^s Inje University College of Medicine   (South Korea)

^t Keimyung University   (South Korea)

^u Dong A University   (South Korea)

^v Sungkyunkwan University School of Medicine   (South Korea)

^w University of Ulsan College of Medicine   (South Korea)

^x Daegu Fatima Hospital   (South Korea)

^y Seoul National University Hospital   (South Korea)

^z Yeungnam University College of Medicine   (South Korea)

^aa Seoul National University Bundang Hospital   (South Korea)

^ab Catholic University of Daegu   (South Korea)

^ac Seoul Veterans Hospital   (South Korea)

^ad Ulsan University College of Medicine   (South Korea)

^ae Kosin University   (South Korea)

^af Gyeongsang National University   (South Korea)

^ag Pusan National University Hospital   (South Korea)

^ah Soonchunhyang University   (South Korea)

^ai Ajou University School of Medicine   (South Korea)

^aj Yonsei University Wonju   (South Korea)

^ak Gachon University College of Medicine   (South Korea)

more..

Author keywords

Multiple myeloma; Stem cell transplantation, autologous; Stem cell transplantation, tandem autologous

Indexed keywords

BORTEZOMIB; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; MELPHALAN; PREDNISOLONE; STEROID; THALIDOMIDE; VINCRISTINE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER REGISTRY; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; INTERNET; KOREA; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; ONLINE SYSTEM; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; INTERNET; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PROGNOSIS; REGISTRIES; REPUBLIC OF KOREA; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 70350543697     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000253027     Document Type: Article

References (22)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43-66.
2. Boyle P, Ferlay J: Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005; 16: 481-488.
3. Ajiki W, Tsukuma H, Oshima A: Cancer incidence and incidence rates in Japan in 1999: estimates based on data from 11 populationbased cancer registries. Jpn J Clin Oncol 2004; 34: 352-356.
4. Huang SY, Yao M, Tang JL, Lee WC, Tsay W, Cheng AL, Wang CH, Chen YC, Shen MC, Tien HF: Epidemiology of multiple myeloma in Taiwan: increasing incidence for the past 25 years and higher prevalence of extramedullary myeloma in patients younger than 55 years. Cancer 2007; 110: 896-905.
5. Kyle RA, Rajkumar SV: Multiple myeloma. Blood 2008; 111: 2962-2972.
6. Kumar SK, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, Zeldenrust SR, Dingli D, Russell SJ, Lust JA, Greipp PR, Kyle RA, Gertz MA: Improved survival in multiple myeloma and the impact of novel therapies. Blood 2008; 111: 2516-2520.
7. Lee JH, Bang SM: Epidemiological change of multiple myeloma in Korea. Korean J Hematol 2006; 41: 225-234.
8. Blade J, Kyle RA: Multiple myeloma in young patients: clinical presentation and treatment approach. Leuk Lymphoma 1998; 30: 493-501.
9. Blade J, Kyle RA, Greipp PR: Presenting features and prognosis in 72 patients with multiple myeloma who were younger than 40 years. Br J Haematol 1996; 93: 345-351. (Pubitemid 26148738)
10. Kastritis E, Zervas K, Symeonidis A, Terpos E, Delimbassi S, Anagnostopoulos N, Michali E, Zomas A, Katodritou E, Gika D, Pouli A, Christoulas D, Roussou M, Kartasis Z, Economopoulos T, Dimopoulos MA: Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG). Leukemia 2009; 23: 1152-1157.
11. Brenner H, Gondos A, Pulte D: Recent major improvement in long-term survival of younger patients with multiple myeloma. Blood 2008; 111: 2521-2526.
12. Barlogie B, Tricot G, Anaissie E, Shaughnessy J, Rasmussen E, van Rhee F, Fassas A, Zangari M, Hollmig K, Pineda-Roman M, Lee C, Talamo G, Thertulien R, Kiwan E, Krishna S, Fox M, Crowley J: Thalidomide and hematopoietic-cell transplantation for multiple myeloma. N Engl J Med 2006; 354: 1021-1030.
13. Child JA, Morgan GJ, Davies FE, Owen RG, Bell SE, Hawkins K, Brown J, Drayson MT, Selby PJ: High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 2003; 348: 1875-1883.
14. Lahuerta JJ, Mateos MV, Martinez-Lopez J, Rosinol L, Sureda A, de la Rubia J, Garcia- Larana J, Martinez-Martinez R, Hernandez- Garcia MT, Carrera D, Besalduch J, de Arriba F, Ribera JM, Escoda L, Hernandez-Ruiz B, Garcia-Frade J, Rivas-Gonzalez C, Alegre A, Blade J, San Miguel JF: Influence of preand post-transplantation responses on outcome of patients with multiple myeloma: sequential improvement of response and achievement of complete response are associated with longer survival. J Clin Oncol 2008; 26: 5775-5782.
15. Niesvizky R, Richardson PG, Rajkumar SV, Coleman M, Rosinol L, Sonneveld P, Schuster MW, Irwin D, Stadtmauer EA, Facon T, Harousseau JL, Boral AL, Esseltine DL, Anderson KC, Blade J: The relationship between quality of response and clinical benefit for patients treated on the bortezomib arm of the international, randomized, phase 3 APEX trial in relapsed multiple myeloma. Br J Haematol 2008; 143: 46-53.
16. Attal M, Harousseau JL, Facon T, Guilhot F, Doyen C, Fuzibet JG, Monconduit M, Hulin C, Caillot D, Bouabdallah R, Voillat L, Sotto JJ, Grosbois B, Bataille R: Single versus double autologous stem-cell transplantation for multiple myeloma. N Engl J Med 2003; 349: 2495-2502.
17. Eom KS, Min CK, Lee S, Kim YJ, Kim SY, Kim HJ, Lee JW, Min WS, Kim CC: Efficacy of up-front treatment with a double stem cell transplantation in multiple myeloma. Jpn J Clin Oncol 2006; 36: 432-438.
18. Lahuerta JJ, Grande C, Martinez-Lopez J, De La Serna J, Toscano R, Ortiz MC, Larregla S, Conde E, Insunza A, Gonzalez-San Miguel JD, Bargay J, Cabrera R, Garcia-Ruiz JC, Albo C, Garcia-Alonso L, Solano F, Vivancos P, Leon A, San Miguel J: Tandem transplants with different high-dose regimens improve the complete remission rates in multiple myeloma. Results of a Grupo Espanol de Sindromes Linfoproliferativos/ Trasplante Autologo de Medula Osea phase II trial. Br J Haematol 2003; 120: 296-303.
19. Kumar A, Kharfan-Dabaja MA, Glasmacher A, Djulbegovic B: Tandem versus single autologous hematopoietic cell transplantation for the treatment of multiple myeloma: a systematic review and meta-analysis. J Natl Cancer Inst 2009; 101: 100-106.
20. Fonseca R, Barlogie B, Bataille R, Bastard C, Bergsagel PL, Chesi M, Davies FE, Drach J, Greipp PR, Kirsch IR, Kuehl WM, Hernandez JM, Minvielle S, Pilarski LM, Shaughnessy JD Jr, Stewart AK, Avet-Loiseau H: Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Res 2004; 64: 1546-1558.
21. Kyle RA, Rajkumar SV: Multiple myeloma. N Engl J Med 2004; 351: 1860-1873.
22. Kuehl WM, Bergsagel PL: Multiple myeloma: evolving genetic events and host interactions. Nat Rev Cancer 2002; 2: 175-187.